Characterization of Cimex lectularius (bedbug) defensin peptide and its antimicrobial activity against human skin microflora

Biochemical and Biophysical Research Communications
Akanksha KaushalMonique L van Hoek

Abstract

Antimicrobial peptides are components of both vertebrate and invertebrate innate immune systems that are expressed in response to exposure to bacterial antigens. Naturally occurring antimicrobial peptides from evolutionarily ancient species have been extensively studied and are being developed as potential therapeutics against antibiotic resistant microorganisms. In this study, a putative Cimex lectularius (bedbug, CL) defensin is characterized for its effectiveness against human skin flora including Gram-negative and Gram-positive bacteria. The bedbug defensin (CL-defensin), belonging to family of insect defensins, is predicted to have a characteristic N-terminal loop, an α-helix, and an antiparallel β-sheet, which was supported by circular dichroism spectroscopy. The defensin was shown to be antimicrobial against Gram-positive bacteria commonly found on human skin (Micrococcus luteus, Corynebacterium renale, Staphylococcus aureus and Staphylococcus epidermidis); however, it was ineffective against common skin Gram-negative bacteria (Pseudomonas aeruginosa and Acinetobacter baumannii) under low-salt conditions. CL-defensin was also effective against M. luteus and C. renale in high-salt (MIC) conditions. Our studies indicate th...Continue Reading

References

Jan 1, 1990·European Journal of Haematology·T GanzR I Lehrer
Jan 1, 1993·Annual Review of Immunology·R I LehrerT Ganz
Aug 1, 1995·Current Opinion in Structural Biology·S H WhiteM E Selsted
Jun 1, 1996·The Journal of Antimicrobial Chemotherapy·A J MooreD A Devine
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·R DaugelaviciusD H Bamford
Sep 20, 2002·BMC Infectious Diseases·Jan LehmannMichael Stöckle
Dec 19, 2003·Nucleic Acids Research·Zhe Wang, Guangshun Wang
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Jan 11, 2005·Protein and Peptide Letters·Philippe Bulet, Reto Stöcklin
Oct 11, 2005·Biotechnology Letters·Kris De Smet, Roland Contreras
Oct 30, 2008·Nucleic Acids Research·Guangshun WangZhe Wang
Apr 20, 2010·Biochemical and Biophysical Research Communications·Lilian S AmerMonique L van Hoek
May 5, 2010·Biochemical and Biophysical Research Communications·Frank A de LatourMonique L van Hoek
Jun 30, 2010·Antimicrobial Agents and Chemotherapy·Raquel F EpandRichard M Epand
Jul 21, 2011·Frontiers in Microbiology·Scott N DeanMonique L van Hoek
Jan 11, 2012·Clinical Microbiology Reviews·Stephen L DoggettRichard C Russell
May 16, 2012·Proceedings of the National Academy of Sciences of the United States of America·Yanyan LiRobert K Ernst
Oct 5, 2013·Folia Microbiologica·Robert NawrotAnna Goździcka-Józefiak
Mar 4, 2014·Pharmaceuticals·Václav Ceřovský, Robert Bém
Oct 4, 2014·Journal of Medical Entomology·Alexis M BarbarinEdwin G Rajotte
Oct 4, 2014·Frontiers in Chemistry·Carlos A RodriguezBarney Bishop

❮ Previous
Next ❯

Citations

Jul 28, 2017·Frontiers in Chemistry·Johannes Koehbach
Sep 1, 2017·Antonie van Leeuwenhoek·Xiaojing XiaJianhe Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.